-transparent.png){kind=logo}
The pharmacokinetics of oral theophylline (250 mg) and the production of its metabolites (3-methylxanthine, 1-methyluric acid, 1,3-dimethyluric acid) were studied before and after the administration of oral terfenadine (120 mg twice daily for 16 days) in 10 healthy volunteers. Comparison of volumes of distribution, elimination half-lives, areas under the plasma concentration-time curves, plasma clearance of theophylline and elimination of theophylline metabolites indicated that terfenadine had no significant effect on theophylline pharmacokinetics and metabolism.
Related Publications
N Brion, and
E Naline, and
D Beaumont, and
M Pays, and
C Advenier
August 1990,
Pharmacology & toxicology,
N Brion, and
E Naline, and
D Beaumont, and
M Pays, and
C Advenier
November 1988,
Clinical pharmacology and therapeutics,
N Brion, and
E Naline, and
D Beaumont, and
M Pays, and
C Advenier
January 1985,
British journal of clinical pharmacology,
N Brion, and
E Naline, and
D Beaumont, and
M Pays, and
C Advenier
January 1993,
Chest,
N Brion, and
E Naline, and
D Beaumont, and
M Pays, and
C Advenier
January 1987,
Chemotherapy,
N Brion, and
E Naline, and
D Beaumont, and
M Pays, and
C Advenier
December 1988,
British journal of clinical pharmacology,
N Brion, and
E Naline, and
D Beaumont, and
M Pays, and
C Advenier
July 1991,
British journal of clinical pharmacology,
N Brion, and
E Naline, and
D Beaumont, and
M Pays, and
C Advenier
May 1999,
The Journal of antimicrobial chemotherapy,
N Brion, and
E Naline, and
D Beaumont, and
M Pays, and
C Advenier
April 1999,
Pharmacology & toxicology,
N Brion, and
E Naline, and
D Beaumont, and
M Pays, and
C Advenier
March 1995,
British journal of clinical pharmacology,
